Pa. Justices Reject Wyeth's Appeal Of $11M Prempro Suit

Law360, Philadelphia (October 17, 2013, 5:06 PM EDT) -- The Pennsylvania Supreme Court on Wednesday shot down an appeal by Pfizer Inc. unit Wyeth Pharmaceuticals Inc. over $11.3 million in compensatory and punitive damages awarded to a woman who alleged that she developed breast cancer after taking the menopause drug Prempro.

The justices rejected a petition by Wyeth asking them to reconsider a January 2010 decision by the state's Superior Court agreeing that the drugmaker systematically ignored warning signs that the hormone replacement drugs Prempro and Provera were linked to breast cancer.

The justices did...
To view the full article, register now.

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.